BACKGROUND: The aim of the study was to investigate the value of percutaneous fine-needle aspiration cytology (FNAC) in the diagnosis and management of @entity96 . METHODS: FNAC followed by histopathological examination was carried out in 216 @entity1 with suspected @entity96 . The final diagnosis was @entity96 in 106, colorectal metastases in 51, non-colorectal metastases in 46, @entity5 in nine and no @entity5 in four @entity1 . RESULTS: Cytology resulted in correct classification of the lesion as benign or malignant in 87 per cent of @entity1 , correct discrimination between primary and secondary @entity5 in half of the @entity1 , and a correct diagnosis of @entity5 type in one-third of @entity1 . The @entity5 was erroneously classified as benign or malignant in 22 @entity1 (11 per cent) and four @entity1 (2 per cent) respectively. When FNAC showed @entity5 , the predictive value was 98 per cent, whereas the predictive value was 27 per cent when it did not. FNAC guided investigations and treatment in one-quarter of @entity1 . Implantation metastases were recorded in seven @entity1 (3 per cent), including five (10 per cent) of 51 @entity1 with colorectal liver metastases, and caused major local problems and @entity204 in four @entity1 . CONCLUSION: FNAC was valuable in about a quarter of @entity1 with @entity96 . The risks of implantation metastases and a false-negative finding do not justify its use in candidates for curative therapy of @entity96 .

Percutaneous fine-needle aspiration cytology in the diagnosis and management of XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death'] @entity5 :: ('MESH:D009369', 'Disease') :: ['benign tumour', 'malignancy', 'tumour'] @entity96 :: ('MESH:D008113', 'Disease') :: ['liver tumours', 'liver tumour', 'primary liver cancer']
@entity96 :: (MESH:D008113,Disease) :: ['liver tumours']
